
Inorganic Chemistry p. 4185 - 4192 (1982)
Update date:2022-08-05
Topics:
Rhodes, Larry F.
Zubkowski, Jeffrey D.
Folting, Kirsten
Huffman, John C.
Caulton, Kenneth G.
MoH4(PMe2Ph)4 reacts with 2 mol of AgBF4 in MeCN to give [MoH2(PMe2Ph)4(NCMe)2](BF 4)2, characterized by spectroscopic methods and X-ray crystallography as containing a fluxional dodecahedral dication. Reaction with equimolar AgBF4 gives no new product but only a reduced yield of the same salt. This oxidation is thus followed by reductive elimination of H2 so that the molybdenum oxidation state suffers no net change. The same salt is obtained by treating the tetrahydride with 2 mol of HBF4·OEt2 in acetonitrile. The identity of the phosphine affects the product isolated: MoH2(PMePh2)4, upon treatment with AgBF4 or HBF4·OEt2 in MeCN, yields MoH2(PMePh2)3(NCMe)32+ with liberation of 1 mol of PMePh2. Possible mechanisms are discussed, as is the relationship between silver oxidation and acidolysis. Crystallographic data (at -160°C) for [MoH2(PMe2Ph)4(NCMe)2](BF 4)2: monoclinic space group P21 with a = 12.359 (6) A?, b = 33.323 (2) A?, c = 13.048 (6) A?, β = 128.61 (2)°, Z = 4. R(F) = 0.0673 for 5037 data collected by diffractometer.
SHAANXI TOP PHARM CHEMICAL CO.LTD
Contact:+86-029-85733403
Address:No.108 ,west sector,south er huan,xi'an,china
ShenZhen InnoSyn Biotech Co.,Ltd
website:http://www.innosyns.com
Contact:+86-755-28351685
Address:Floor 5 & 6, Building A1, HAIKEXING Strategic Innovative Industrial Park, 16 BaoShan Road, PingShan District
WUHU HUAHAI BIOLOGY ENGINEERING CO LTD
Contact:+86-553-3836920
Address:7/F NO.82 LAODONG ROAD WUHU CHINA
Tianjin Boron PharmaTech Co.,Ltd.(expird)
Contact:86-022-59845187
Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
website:http://www.enbridgepharm.com
Contact:+86-510-83591909
Address:Huishan Zone, Wuxi City, Jiangsu Province, P.R.China
Doi:10.1016/j.bmcl.2011.03.007
(2011)Doi:10.1002/zaac.19794590104
(1979)Doi:10.1271/bbb1961.46.2169
(1982)Doi:10.1002/chem.200900149
(2009)Doi:10.1016/S0040-4039(98)01610-4
(1998)Doi:10.1039/c9ra02394a
(2019)